Company Filing History:
2 out of 210 
2 out of 18 
1 out of 592 Years Active: 2019-2025
Title: The Innovative Contributions of Jee Youn Lee
Introduction
Jee Youn Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 5 patents to his name, Lee's work has the potential to impact various medical conditions.
Latest Patents
One of Jee Youn Lee's latest patents is titled "Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof." This patent provides antibodies that specifically bind to human FAM19A5 and compositions comprising such antibodies. The antibodies are designed to modulate FAM19A5 activity, which may include inhibiting, suppressing, reducing, or reversing the onset of reactive gliosis and excessive proliferation of reactive astrocytes. Furthermore, the patent outlines methods for treating disorders such as central nervous system damage, degenerative brain disorders, or neuropathic pain by administering these specific antibodies.
Career Highlights
Throughout his career, Jee Youn Lee has worked with notable companies, including Coway Co., Ltd and Neuracle Science Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Jee Youn Lee has collaborated with several professionals in his field, including Tae Young Yune and Young Jo Kim. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.
Conclusion
Jee Youn Lee's innovative work in biotechnology, particularly in the development of antibodies, showcases his significant contributions to medical science. His patents reflect a commitment to addressing critical health issues through scientific advancements.